Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CStone received IND approval in China for HDAC6 inhibitor CS3003 2019-03-13 10:10
Hematogenix Launches FDA Approved Companion Diagnostic Immuno-oncology Test for Triple-Negative Breast Cancer 2019-03-13 04:28
Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth 2019-03-12 19:00
Medtec China 2019 scales up by 21% with a strong increase in new exhibitors 2019-03-12 12:13
Positive Interim Analysis in Pivotal IsoConDa Phase III Study 2019-03-08 15:33
Santen to Conduct Activities to Raise Disease Awareness during World Glaucoma Week, March 10 to 16 2019-03-08 13:00
Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and voting agreements with two additional significant shareholders 2019-03-08 03:54
Seize the Strategic Market of the Livestock Industry, and Build an Integrated Professional Platform for Veterinary Drugs 2019-03-07 15:00
Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatment of HPV-Related Cervical Pre-cancer 2019-03-04 21:00
Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study 2019-03-04 09:45
3SBio and TLC Form Exclusive Partnership to Commercialize Two NanoX(TM) Products in Mainland China 2019-03-04 07:00
New Data Affirms Strength of UCB Immuno-Dermatology Portfolio 2019-03-01 20:56
Galderma: New Data Reveals Benefits of Combining Oral and Topical Treatment in Patients With Severe Papulopustular Rosacea 2019-03-01 20:33
Rakuten Aspyrian Announces Name Change to Rakuten Medical 2019-03-01 14:10
Pius S. Hornstein, PhD, Appointed New Country Chair of Sanofi China 2019-03-01 10:07
Tessa Therapeutics Names Biopharma Veteran Jeffrey H. Buchalter to Board of Directors 2019-03-01 07:15
WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA 2019-02-28 09:52
First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma 2019-02-28 08:30
Innovent Receives IFR Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 Awards 2019-02-27 12:00
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies 2019-02-26 08:07
1 200 201 202 203 204 247